Oxytocin, clinical outcomes, and patient choi...

The new trade deal struck between the UK and US came into force in April. The deal will double the amount that the NHS spends on new medicines, by the end of 2036 (from 0.6 - 0.6% of GDP). increase the threshold that the National Institute for Health and Care Excellence (NICE) se ...  Show more

A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among agency reviewers regarding its efficacy. We look to Sweden, w ...  Show more

Please listen to our latest episode of The Lebanese Physicians' Podcast discussing clincial informatics in primary care and its role in enhancing access to primary care and preventive care. This episode is co-hosted with Dr. MohammadAli Jardaly. Our guest is Dr. Ramy Khalil wh ...

Please listen to and watch this latest episode of The Lebanese Physicians' Podcast with Dr. Lama El Zein MD, MHA. Dr. El Zein just started a position as Vice President, Quality and Implementation Science at Hackensack Meridian Health in New Jersey.

In this episode, we d ...

WHOOP VP of Performance Kristen Holmes sits down with Arena Labs founder and CEO Brian Ferguson to discuss the future of healthcare and how hospitals and medical organizations can optimize performance in the operating room, the ICU, and beyond. Brian dives deep on his transiti ...

In Episode 5, guests Terri Murrray, RN and Jonathan Armenti, RN join us for a discussion about the role of nurses in dialysis and kidney transplantation in the care of patients with kidney disease. They discuss their journeys to their current careers, challenges faced by our pati ...  Show more